12th ASM Conference on Candida and Candidiasis

第 12 届 ASM 念珠菌和念珠菌病会议

• 批准号: 8651701
• 负责人: Theodore C. White
• 金额: $ 0.8万
• 依托单位: AMERICAN SOCIETY FOR MICROBIOLOGY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-02-01 至 2015-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8651701
• 关键词: AIDS/HIV problem; Achievement; Acquired Immunodeficiency Syndrome; Address; Affect; Agreement; American; Antifungal Agents; Area; Azoles; Biological; Candida; Candida albicans; Candida glabrata; Candidiasis; Case Study; Cell Communication; Chemotherapy-Oncologic Procedure; Clinical; Collaborations; Communicable Diseases; Communities; Community Developments; Development; Diagnosis; Disease; Disseminated candidiasis; Drug Interactions; Drug resistance; Educational workshop; Effectiveness; Epidemiology; Esophageal; Failure; Feedback; Filler; Financial Support; Frequencies; Funding; Fungal Drug Resistance; Genes; Genomics; Goals; Growth; Guidelines; Healthcare; Host Defense; Human; Imagination; Immune; Immune response; Immunocompetent; Immunocompromised Host; Immunology; Individual; Infection; International; Lead; Life; Medical; Metabolic; Microbial Biofilms; Microbiology; Minority; Modeling; Molecular; Morphogenesis; Names; Neonatal Intensive Care Units; Oral; Oropharyngeal; Participant; Partner in relationship; Pathogenicity; Patients; Premature Infant; Prophylactic treatment; Proteomics; Publications; Recording of previous events; Research; Research Personnel; Resources; Role; San Francisco; Scientist; Series; Signal Transduction; Societies; Surveys; System; Systems Biology; Techniques; Technology; The science of Mycology; Time; Training; Vaccines; Vagina; Woman; abstracting; base; candidemia; career; flexibility; fungus; genome annotation; genome sequencing; in vivo; interest; meetings; member; mutant; new technology; pathogen; posters; prevent; programs; public health relevance; resistance mechanism; response; screening; success; symposium; therapeutic vaccine; tool; transcriptomics

DESCRIPTION (provided by applicant): Candida is the major fungal pathogen of humans, causing diseases that range from oral and vaginal candidiasis to life-threatening candidemia and invasive disease. The Candida field focuses on a broad spectrum of subjects that relate to epidemiology, drug resistance, infection, host response, vaccines and therapeutics. The Candida and Candidiasis Conference, held every two years, is the premier forum for presentation of cutting-edge advances and the latest perspectives in these diverse areas. Funds are requested to provide partial support for the 12th Conference on Candida and Candidiasis, which will be held from 26-30 March, 2014, in New Orleans, LA. The conference will be sponsored by the American Society for Microbiology, which will provide both management expertise and financial support. The program will be based upon past conferences in the series, which have reliably drawn attendance of around 400 American and International scientists, and have been met with enthusiastic support in participant surveys. This program will include 34 speakers chosen for their expertise in fundamental and/or clinical mycology and 62 speakers who will be selected based on submitted abstracts. This arrangement will provide the flexibility to present cutting-edge advances and to enlist a diverse spectrum of emerging and established community members as speakers. There will be clinical talks about the epidemiology, diagnosis, and treatment of candidiasis, with speakers carefully prescreened for affability and effectiveness. These talks will be incorporated into sessions that focus on various key aspects of candidal infections, including environmental signaling, antifungal agents and resistance, immune recognition, vaccines, morphogenesis, and biofilms. In a lunch session on Candida case reports, clinicians will inform basic scientists about the challenges of diagnosing and treating different types of infection. Informal parallel sessions will address infection models, metabolic adaptation, fungal drug interactions and new technologies while further encouraging productive interaction and discussion. There will be a poster session each afternoon to allow ample discussion of the 250-300 posters that will be presented. We are confident that our goals - to present the latest advances in the field, to spotlight achievements of junior scientists (especially women and minorities), to promote synergistic and interdisciplinary interactions, and to provide a venue for community-wide discussion - will be achieved.

描述(申请人提供)：念珠菌是人类的主要真菌病原体，可引起从口腔和阴道念珠菌病到危及生命的念珠菌症和侵袭性疾病。念珠菌领域专注于与流行病学、耐药性、感染、宿主反应、疫苗和治疗学有关的广泛主题。念珠菌和念珠菌病会议每两年举行一次，是介绍这些不同领域的前沿进展和最新观点的主要论坛。请拨资金为将于2014年3月26日至30日在洛杉矶新奥尔良举行的第12届念珠菌和念珠菌病会议提供部分支助。这次会议将由美国微生物学会主办，该学会将提供管理专业知识和资金支持。该计划将以该系列过去的会议为基础，可靠地吸引了大约400名美国和国际科学家参加，并在参与者调查中得到了热情的支持。该计划将包括34名演讲者因他们在基础和/或临床真菌学方面的专业知识而被选中，62名演讲者将根据提交的摘要进行选择。这一安排将提供灵活性，以介绍前沿进展，并招募各种新兴和成熟的社区成员作为演讲者。将有关于念珠菌病的流行病学、诊断和治疗的临床讲座，演讲者将经过仔细的亲和力和有效性筛选。这些讲座将被纳入重点关注念珠菌感染的各个关键方面的会议，包括环境信号、抗真菌药物和耐药性、免疫识别、疫苗、形态发生和生物被膜。在关于念珠菌病例报告的午餐会议上，临床医生将向基础科学家通报诊断和治疗不同类型感染的挑战。非正式平行会议将讨论感染模型、新陈代谢适应、真菌药物相互作用和新技术，同时进一步鼓励富有成效的互动和讨论。每天下午将有一个海报会议，以便对将展示的250-300张海报进行充分讨论。我们相信，我们的目标--展示该领域的最新进展，突出初级科学家(特别是妇女和少数群体)的成就，促进协同和跨学科互动，以及提供一个供社区广泛讨论的场所--将会实现。